130 related articles for article (PubMed ID: 11393357)
1. Sugar-mediated crosslinking of alpha-biotinylated-Lys to cysteamine-agarose support: a method to isolate Maillard Lys-Lys-like crosslinks.
Linetsky M; LeGrand RD; Mossine VV; Ortwerth BJ
Appl Biochem Biotechnol; 2001 Apr; 94(1):71-96. PubMed ID: 11393357
[TBL] [Abstract][Full Text] [Related]
2. Protein modification by the degradation products of ascorbate: formation of a novel pyrrole from the Maillard reaction of L-threose with proteins.
Nagaraj RH; Monnier VM
Biochim Biophys Acta; 1995 Nov; 1253(1):75-84. PubMed ID: 7492603
[TBL] [Abstract][Full Text] [Related]
3. A systematic approach to evaluate the modification of lens proteins by glycation-induced crosslinking.
Lee KW; Simpson G; Ortwerth B
Biochim Biophys Acta; 1999 Jan; 1453(1):141-51. PubMed ID: 9989254
[TBL] [Abstract][Full Text] [Related]
4. Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.
Sady C; Jiang CL; Chellan P; Madhun Z; Duve Y; Glomb MA; Nagaraj RH
Biochim Biophys Acta; 2000 Sep; 1481(2):255-64. PubMed ID: 11018716
[TBL] [Abstract][Full Text] [Related]
5. Triosidines: novel Maillard reaction products and cross-links from the reaction of triose sugars with lysine and arginine residues.
Tessier FJ; Monnier VM; Sayre LM; Kornfield JA
Biochem J; 2003 Feb; 369(Pt 3):705-19. PubMed ID: 12379150
[TBL] [Abstract][Full Text] [Related]
6. Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes.
Chellan P; Nagaraj RH
Arch Biochem Biophys; 1999 Aug; 368(1):98-104. PubMed ID: 10415116
[TBL] [Abstract][Full Text] [Related]
7. Formation of Pentosidine Cross-Linking in Myoglobin by Glyoxal: Detection of Fluorescent Advanced Glycation End Product.
Banerjee S
J Fluoresc; 2017 Jul; 27(4):1213-1219. PubMed ID: 28299531
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of advanced glycation end product-associated protein cross-linking.
Lehman TD; Ortwerth BJ
Biochim Biophys Acta; 2001 Feb; 1535(2):110-9. PubMed ID: 11341999
[TBL] [Abstract][Full Text] [Related]
9. Determination of glycation crosslinking by the sugar-dependent incorporation of [14C]lysine into protein.
Prabhakaram M; Ortwerth BJ
Anal Biochem; 1994 Feb; 216(2):305-12. PubMed ID: 8179185
[TBL] [Abstract][Full Text] [Related]
10. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.
Reddy S; Bichler J; Wells-Knecht KJ; Thorpe SR; Baynes JW
Biochemistry; 1995 Aug; 34(34):10872-8. PubMed ID: 7662668
[TBL] [Abstract][Full Text] [Related]
11. New biomarkers of Maillard reaction damage to proteins.
Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
[TBL] [Abstract][Full Text] [Related]
12. Favored and disfavored pathways of protein crosslinking by glucose: glucose lysine dimer (GLUCOLD) and crossline versus glucosepane.
Nemet I; Strauch CM; Monnier VM
Amino Acids; 2011 Jan; 40(1):167-81. PubMed ID: 20607325
[TBL] [Abstract][Full Text] [Related]
13. Lysine-Derived Protein-Bound Heyns Compounds in Bakery Products.
Treibmann S; Hellwig A; Hellwig M; Henle T
J Agric Food Chem; 2017 Dec; 65(48):10562-10570. PubMed ID: 29111707
[TBL] [Abstract][Full Text] [Related]
14. Determination of early glycation products by mass spectrometry and quantification of glycation mediated protein crosslinks by the incorporation of [14C]lysine into proteins.
Prabhakaram M; Ortwerth BJ; Smith JB
Methods Mol Biol; 2000; 159():245-53. PubMed ID: 11050729
[No Abstract] [Full Text] [Related]
15. Protein cross-linking by the Maillard reaction. Isolation, characterization, and in vivo detection of a lysine-lysine cross-link derived from methylglyoxal.
Nagaraj RH; Shipanova IN; Faust FM
J Biol Chem; 1996 Aug; 271(32):19338-45. PubMed ID: 8702619
[TBL] [Abstract][Full Text] [Related]
16. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.
Takeuchi M; Makita Z; Bucala R; Suzuki T; Koike T; Kameda Y
Mol Med; 2000 Feb; 6(2):114-25. PubMed ID: 10859028
[TBL] [Abstract][Full Text] [Related]
17. Chemical Synthesis of Peptides Containing Site-Specific Advanced Glycation Endproducts.
Kaur H; Kamalov M; Brimble MA
Acc Chem Res; 2016 Oct; 49(10):2199-2208. PubMed ID: 27672697
[TBL] [Abstract][Full Text] [Related]
18. Structure of a synthetic glucose derived advanced glycation end product that is immunologically cross-reactive with its naturally occurring counterparts.
Al-Abed Y; Bucala R
Bioconjug Chem; 2000; 11(1):39-45. PubMed ID: 10639083
[TBL] [Abstract][Full Text] [Related]
19. Alternative routes for the formation of immunochemically distinct advanced glycation end-products in vivo.
Takeuchi M; Makita Z
Curr Mol Med; 2001 Jul; 1(3):305-15. PubMed ID: 11899079
[TBL] [Abstract][Full Text] [Related]
20. Biophysical and mass spectrometry based characterization of methylglyoxal-modified myoglobin: Role of advanced glycation end products in inducing protein structural alterations.
Banerjee S
Int J Biol Macromol; 2021 Dec; 193(Pt B):2165-2172. PubMed ID: 34774865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
